ArticleTherapeutic advances in neurological disorders2025

CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study.

Domenico Plantone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.